{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T22:58:22Z","timestamp":1780095502629,"version":"3.54.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,1]]},"DOI":"10.7759\/cureus.72816","type":"journal-article","created":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T09:00:37Z","timestamp":1730451637000},"source":"Crossref","is-referenced-by-count":6,"title":["Unraveling Pancreatic Cancer: Epidemiology, Risk Factors, and Global Trends"],"prefix":"10.7759","author":[{"given":"Rana Muhammad Anss Bin","family":"Qadir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Musab Bin","family":"Umair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umar Bin","family":"Tariq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arslan","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wajeeha","family":"Kiran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Hasaan","family":"Shahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v27.i27.4298","article-title":"Pancreatic cancer: a review of epidemiology, trend, and risk factors","volume":"27","author":"Hu JX","year":"2021","unstructured":"Hu JX, Zhao CF, Chen WB, Liu QC, Li QW, Lin YY, Gao F. Pancreatic cancer: a review of epidemiology, trend, and risk factors. World J Gastroenterol. 2021, 27:4298-321. 10.3748\/wjg.v27.i27.4298","journal-title":"World J Gastroenterol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.14740\/wjon1166","article-title":"Epidemiology of pancreatic cancer: global trends, etiology and risk factors","volume":"10","author":"Rawla P","year":"2019","unstructured":"Rawla P, Sunkara T, Gaduputi V. Epidemiology of pancreatic cancer: global trends, etiology and risk factors. World J Oncol. 2019, 10:10-27. 10.14740\/wjon1166","journal-title":"World J Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v28.i32.4698","article-title":"International patterns in incidence and mortality trends of pancreatic cancer in the last three decades: a joinpoint regression analysis","volume":"28","author":"Ilic I","year":"2022","unstructured":"Ilic I, Ilic M. International patterns in incidence and mortality trends of pancreatic cancer in the last three decades: a joinpoint regression analysis. World J Gastroenterol. 2022, 28:4698-715. 10.3748\/wjg.v28.i32.4698","journal-title":"World J Gastroenterol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2019.05.059","article-title":"Racial disparities and trends in pancreatic cancer incidence and mortality in the United States","volume":"18","author":"Tavakkoli A","year":"2020","unstructured":"Tavakkoli A, Singal AG, Waljee AK, et al.. Racial disparities and trends in pancreatic cancer incidence and mortality in the United States. Clin Gastroenterol Hepatol. 2020, 18:171-178.e10. 10.1016\/j.cgh.2019.05.059","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.gtc.2022.06.006","article-title":"Familial pancreatic cancer","volume":"51","author":"Saba H","year":"2022","unstructured":"Saba H, Goggins M. Familial pancreatic cancer. Gastroenterol Clin North Am. 2022, 51:561-75. 10.1016\/j.gtc.2022.06.006","journal-title":"Gastroenterol Clin North Am"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/jso.27462","article-title":"Global trends in the incidence and mortality of pancreatic cancer based on geographic location, socioeconomic status, and demographic shift","volume":"128","author":"Sharma P","year":"2023","unstructured":"Sharma P, Vuthaluru S, Chowdhury S, Are C. Global trends in the incidence and mortality of pancreatic cancer based on geographic location, socioeconomic status, and demographic shift. J Surg Oncol. 2023, 128:989-1002. 10.1002\/jso.27462","journal-title":"J Surg Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15030870","article-title":"Pancreatic cancer incidence trends by race, ethnicity, age and sex in the United States: a population-based study, 2000-2018","volume":"15","author":"Samaan JS","year":"2023","unstructured":"Samaan JS, Abboud Y, Oh J, et al.. Pancreatic cancer incidence trends by race, ethnicity, age and sex in the United States: a population-based study, 2000-2018. Cancers (Basel). 2023, 15:10.3390\/cancers15030870","journal-title":"Cancers (Basel)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2023.7060","article-title":"Smoking cessation and pancreatic cancer risk in individuals with prediabetes and diabetes: a nationwide cohort study","volume":"21","author":"Park JH","year":"2023","unstructured":"Park JH, Hong JY, Shen JJ, Han K, Park YS, Park JO. Smoking cessation and pancreatic cancer risk in individuals with prediabetes and diabetes: a nationwide cohort study. J Natl Compr Canc Netw. 2023, 21:1149-1155.e3. 10.6004\/jnccn.2023.7060","journal-title":"J Natl Compr Canc Netw"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.06.079","article-title":"Diversity and inclusion in pancreatic cancer clinical trials","volume":"161","author":"Herremans KM","year":"2021","unstructured":"Herremans KM, Riner AN, Winn RA, Trevino JG. Diversity and inclusion in pancreatic cancer clinical trials. Gastroenterology. 2021, 161:1741-1746.e3. 10.1053\/j.gastro.2021.06.079","journal-title":"Gastroenterology"},{"key":"ref10","article-title":"Systematic review of the predictors of health service use in pancreatic cancer","volume":"12","author":"Khan NN","year":"2022","unstructured":"Khan NN, Lewin T, Hatton A, et al.. Systematic review of the predictors of health service use in pancreatic cancer. Am J Cancer Res. 2022, 12:622-50.","journal-title":"Am J Cancer Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v24.i19.2047","article-title":"Challenges in diagnosis of pancreatic cancer","volume":"24","author":"Zhang L","year":"2018","unstructured":"Zhang L, Sanagapalli S, Stoita A. Challenges in diagnosis of pancreatic cancer. World J Gastroenterol. 2018, 24:2047-60. 10.3748\/wjg.v24.i19.2047","journal-title":"World J Gastroenterol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i31.10778","article-title":"Genetic predisposition to pancreatic cancer","volume":"20","author":"Ghiorzo P","year":"2014","unstructured":"Ghiorzo P. Genetic predisposition to pancreatic cancer. World J Gastroenterol. 2014, 20:10778-89. 10.3748\/wjg.v20.i31.10778","journal-title":"World J Gastroenterol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.soc.2021.06.002","article-title":"Inherited pancreatic cancer syndromes and high-risk screening","volume":"30","author":"Biller LH","year":"2021","unstructured":"Biller LH, Wolpin BM, Goggins M. Inherited pancreatic cancer syndromes and high-risk screening. Surg Oncol Clin N Am. 2021, 30:773-86. 10.1016\/j.soc.2021.06.002","journal-title":"Surg Oncol Clin N Am"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2196\/21582","article-title":"Use of social media to promote cancer screening and early diagnosis: scoping review","volume":"22","author":"Plackett R","year":"2020","unstructured":"Plackett R, Kaushal A, Kassianos AP, et al.. Use of social media to promote cancer screening and early diagnosis: scoping review. J Med Internet Res. 2020, 22:e21582. 10.2196\/21582","journal-title":"J Med Internet Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0166449","article-title":"The impact of socioeconomic status, surgical resection and type of hospital on survival in patients with pancreatic cancer. A population-based study in the Netherlands","volume":"11","author":"van Roest MH","year":"2016","unstructured":"van Roest MH, van der Aa MA, van der Geest LG, de Jong KP. The impact of socioeconomic status, surgical resection and type of hospital on survival in patients with pancreatic cancer. A population-based study in the Netherlands. PLoS One. 2016, 11:e0166449. 10.1371\/journal.pone.0166449","journal-title":"PLoS One"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/nutrit\/nux038","article-title":"Dietary patterns and risk of pancreatic cancer: a systematic review","volume":"75","author":"Zheng J","year":"2017","unstructured":"Zheng J, Guinter MA, Merchant AT, Wirth MD, Zhang J, Stolzenberg-Solomon RZ, Steck SE. Dietary patterns and risk of pancreatic cancer: a systematic review. Nutr Rev. 2017, 75:883-908. 10.1093\/nutrit\/nux038","journal-title":"Nutr Rev"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.45259","article-title":"On the menu: analyzing the macronutrients, micronutrients, beverages, dietary patterns, and pancreatic cancer risk","volume":"15","author":"Mukhtar S","year":"2023","unstructured":"Mukhtar S, Moradi A, Kodali A, et al.. On the menu: analyzing the macronutrients, micronutrients, beverages, dietary patterns, and pancreatic cancer risk. Cureus. 2023, 15:e45259. 10.7759\/cureus.45259","journal-title":"Cureus"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/697521","article-title":"The role of chronic inflammation in obesity-associated cancers","volume":"2013","author":"Ramos-Nino ME","year":"2013","unstructured":"Ramos-Nino ME. The role of chronic inflammation in obesity-associated cancers. ISRN Oncol. 2013, 2013:697521. 10.1155\/2013\/697521","journal-title":"ISRN Oncol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.26288","article-title":"The role of type 2 diabetes in pancreatic cancer","volume":"14","author":"George S","year":"2022","unstructured":"George S, Jean-Baptiste W, Yusuf Ali A, et al.. The role of type 2 diabetes in pancreatic cancer. Cureus. 2022, 14:e26288. 10.7759\/cureus.26288","journal-title":"Cureus"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.06.024","article-title":"New-onset diabetes and pancreatic cancer","volume":"4","author":"Gupta S","year":"2006","unstructured":"Gupta S, Vittinghoff E, Bertenthal D, Corley D, Shen H, Walter LC, McQuaid K. New-onset diabetes and pancreatic cancer. Clin Gastroenterol Hepatol. 2006, 4:1366-72; quiz 1301. 10.1016\/j.cgh.2006.06.024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.2174\/1871530320666200423095700","article-title":"Chronic pancreatitis and the development of pancreatic cancer","volume":"20","author":"Kandikattu HK","year":"2020","unstructured":"Kandikattu HK, Venkateshaiah SU, Mishra A. Chronic pancreatitis and the development of pancreatic cancer. Endocr Metab Immune Disord Drug Targets. 2020, 20:1182-210. 10.2174\/1871530320666200423095700","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13143581","article-title":"Occupational exposure to carcinogens and occupational epidemiological cancer studies in Iran: a review","volume":"13","author":"Hosseini B","year":"2021","unstructured":"Hosseini B, Hall AL, Zendehdel K, et al.. Occupational exposure to carcinogens and occupational epidemiological cancer studies in Iran: a review. Cancers (Basel). 2021, 13:10.3390\/cancers13143581","journal-title":"Cancers (Basel)"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2021.111608","article-title":"The association between ambient air pollutants and pancreatic cancer in the Multiethnic Cohort Study","volume":"202","author":"Bogumil D","year":"2021","unstructured":"Bogumil D, Wu AH, Stram D, et al.. The association between ambient air pollutants and pancreatic cancer in the Multiethnic Cohort Study. Environ Res. 2021, 202:111608. 10.1016\/j.envres.2021.111608","journal-title":"Environ Res"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-13-111","article-title":"Pancreatic cancer clusters and arsenic-contaminated drinking water wells in Florida","volume":"13","author":"Liu-Mares W","year":"2013","unstructured":"Liu-Mares W, Mackinnon JA, Sherman R, Fleming LE, Rocha-Lima C, Hu JJ, Lee DJ. Pancreatic cancer clusters and arsenic-contaminated drinking water wells in Florida. BMC Cancer. 2013, 13:111. 10.1186\/1471-2407-13-111","journal-title":"BMC Cancer"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.01.259","article-title":"Early detection of pancreatic cancer: opportunities and challenges","volume":"156","author":"Singhi AD","year":"2019","unstructured":"Singhi AD, Koay EJ, Chari ST, Maitra A. Early detection of pancreatic cancer: opportunities and challenges. Gastroenterology. 2019, 156:2024-40. 10.1053\/j.gastro.2019.01.259","journal-title":"Gastroenterology"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14102539","article-title":"Imaging modalities for early detection of pancreatic cancer: current state and future research opportunities","volume":"14","author":"Farr KP","year":"2022","unstructured":"Farr KP, Moses D, Haghighi KS, Phillips PA, Hillenbrand CM, Chua BH. Imaging modalities for early detection of pancreatic cancer: current state and future research opportunities. Cancers (Basel). 2022, 14:10.3390\/cancers14102539","journal-title":"Cancers (Basel)"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14102476","article-title":"Multi-phase, contrast-enhanced computed tomography-based radiomic prognostic marker of non-metastatic pancreatic ductal adenocarcinoma","volume":"14","author":"Shin DW","year":"2022","unstructured":"Shin DW, Park J, Lee JC, Kim J, Kim YH, Hwang JH. Multi-phase, contrast-enhanced computed tomography-based radiomic prognostic marker of non-metastatic pancreatic ductal adenocarcinoma. Cancers (Basel). 2022, 14:10.3390\/cancers14102476","journal-title":"Cancers (Basel)"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.mric.2014.04.009","article-title":"Diffusion-weighted imaging of the liver: techniques and applications","volume":"22","author":"Lewis S","year":"2014","unstructured":"Lewis S, Dyvorne H, Cui Y, Taouli B. Diffusion-weighted imaging of the liver: techniques and applications. Magn Reson Imaging Clin N Am. 2014, 22:373-95. 10.1016\/j.mric.2014.04.009","journal-title":"Magn Reson Imaging Clin N Am"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s13193-011-0042-1","article-title":"Serum CA 19-9 as a biomarker for pancreatic cancer-a comprehensive review","volume":"2","author":"Ballehaninna UK","year":"2011","unstructured":"Ballehaninna UK, Chamberlain RS. Serum CA 19-9 as a biomarker for pancreatic cancer-a comprehensive review. Indian J Surg Oncol. 2011, 2:88-100. 10.1007\/s13193-011-0042-1","journal-title":"Indian J Surg Oncol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16071377","article-title":"The role of circulating tumor cells as a liquid biopsy for cancer: advances, biology, technical challenges, and clinical relevance","volume":"16","author":"Allen TA","year":"2024","unstructured":"Allen TA. The role of circulating tumor cells as a liquid biopsy for cancer: advances, biology, technical challenges, and clinical relevance. Cancers (Basel). 2024, 16:10.3390\/cancers16071377","journal-title":"Cancers (Basel)"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911521","article-title":"Tumor-informed approach improved ctDNA detection rate in resected pancreatic cancer","volume":"23","author":"Watanabe K","year":"2022","unstructured":"Watanabe K, Nakamura T, Kimura Y, et al.. Tumor-informed approach improved ctDNA detection rate in resected pancreatic cancer. Int J Mol Sci. 2022, 23:10.3390\/ijms231911521","journal-title":"Int J Mol Sci"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-73525-y","article-title":"The actual 5-year survivors of pancreatic ductal adenocarcinoma based on real-world data","volume":"10","author":"Bengtsson A","year":"2020","unstructured":"Bengtsson A, Andersson R, Ansari D. The actual 5-year survivors of pancreatic ductal adenocarcinoma based on real-world data. Sci Rep. 2020, 10:16425. 10.1038\/s41598-020-73525-y","journal-title":"Sci Rep"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i11.3157","article-title":"Update on the management of pancreatic cancer: surgery is not enough","volume":"21","author":"Ansari D","year":"2015","unstructured":"Ansari D, Gustafsson A, Andersson R. Update on the management of pancreatic cancer: surgery is not enough. World J Gastroenterol. 2015, 21:3157-65. 10.3748\/wjg.v21.i11.3157","journal-title":"World J Gastroenterol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.11466","article-title":"Whipple procedure: a five-year clinical experience in tertiary care center","volume":"12","author":"Changazi SH","year":"2020","unstructured":"Changazi SH, Ahmed Q, Bhatti S, Siddique S, Abdul Raffay E, Farooka MW, Ayyaz M. Whipple procedure: a five-year clinical experience in tertiary care center. Cureus. 2020, 12:e11466. 10.7759\/cureus.11466","journal-title":"Cureus"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-021-02159-9","article-title":"Improvement in distal pancreatectomy for tumors in the body and tail of the pancreas","volume":"19","author":"Jiang L","year":"2021","unstructured":"Jiang L, Ning D, Chen XP. Improvement in distal pancreatectomy for tumors in the body and tail of the pancreas. World J Surg Oncol. 2021, 19:49. 10.1186\/s12957-021-02159-9","journal-title":"World J Surg Oncol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2013.08.012","article-title":"Insulin dependence and pancreatic enzyme replacement therapy are independent prognostic factors for long-term survival after operation for chronic pancreatitis","volume":"155","author":"Winny M","year":"2014","unstructured":"Winny M, Paroglou V, Bektas H, et al.. Insulin dependence and pancreatic enzyme replacement therapy are independent prognostic factors for long-term survival after operation for chronic pancreatitis. Surgery. 2014, 155:271-9. 10.1016\/j.surg.2013.08.012","journal-title":"Surgery"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32409-6","article-title":"Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC- 4): a multicentre, open-label, randomised, phase 3 trial. The","volume":"389","author":"Neoptolemos JP","year":"2017","unstructured":"Neoptolemos JP, Palmer DH, Ghaneh P, et al.. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC- 4): a multicentre, open-label, randomised, phase 3 trial. The. Lancet. 2017, 389:1011-24. 10.1016\/S0140-6736(16)32409-6","journal-title":"Lancet"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2021.10.023","article-title":"Neoadjuvant therapy or upfront surgery for resectable\u00a0and borderline resectable pancreatic cancer: a\u00a0meta-analysis of randomised controlled trials","volume":"160","author":"van Dam JL","year":"2022","unstructured":"van Dam JL, Janssen QP, Besselink MG, et al.. Neoadjuvant therapy or upfront surgery for resectable\u00a0and borderline resectable pancreatic cancer: a\u00a0meta-analysis of randomised controlled trials. Eur J Cancer. 2022, 160:140-9. 10.1016\/j.ejca.2021.10.023","journal-title":"Eur J Cancer"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12113677","article-title":"Neoadjuvant treatments for pancreatic ductal adenocarcinoma: where we are and where we are going","volume":"12","author":"Coppola A","year":"2023","unstructured":"Coppola A, Farolfi T, La Vaccara V, et al.. Neoadjuvant treatments for pancreatic ductal adenocarcinoma: where we are and where we are going. J Clin Med. 2023, 12:10.3390\/jcm12113677","journal-title":"J Clin Med"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15020416","article-title":"Optimizing first-line chemotherapy in metastatic pancreatic cancer: efficacy of FOLFIRINOX versus nab-paclitaxel plus gemcitabine","volume":"15","author":"Di Costanzo F","year":"2023","unstructured":"Di Costanzo F, Di Costanzo F, Antonuzzo L, Mazza E, Giommoni E. Optimizing first-line chemotherapy in metastatic pancreatic cancer: efficacy of FOLFIRINOX versus nab-paclitaxel plus gemcitabine. Cancers (Basel). 2023, 15:10.3390\/cancers15020416","journal-title":"Cancers (Basel)"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15133382","article-title":"Radiotherapy in pancreatic cancer: to whom, when, and how?","volume":"15","author":"Falco M","year":"2023","unstructured":"Falco M, Masoj\u0107 B, Sulikowski T. Radiotherapy in pancreatic cancer: to whom, when, and how?. Cancers (Basel). 2023, 15:10.3390\/cancers15133382","journal-title":"Cancers (Basel)"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10102480","article-title":"Stereotactic body radiotherapy (SBRT) of pancreatic cancer-a critical review and practical consideration","volume":"10","author":"Burko\u0148 P","year":"2022","unstructured":"Burko\u0148 P, Trna J, Sl\u00e1vik M, et al.. Stereotactic body radiotherapy (SBRT) of pancreatic cancer-a critical review and practical consideration. Biomedicines. 2022, 10:10.3390\/biomedicines10102480","journal-title":"Biomedicines"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14112619","article-title":"The next frontier in pancreatic cancer: targeting the tumor immune milieu and molecular pathways","volume":"14","author":"Yin C","year":"2022","unstructured":"Yin C, Alqahtani A, Noel MS. The next frontier in pancreatic cancer: targeting the tumor immune milieu and molecular pathways. Cancers (Basel). 2022, 14:10.3390\/cancers14112619","journal-title":"Cancers (Basel)"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2021.01.031","article-title":"Trials and tribulations of pancreatic cancer immunotherapy","volume":"504","author":"Principe DR","year":"2021","unstructured":"Principe DR, Korc M, Kamath SD, Munshi HG, Rana A. Trials and tribulations of pancreatic cancer immunotherapy. Cancer Lett. 2021, 504:1-14. 10.1016\/j.canlet.2021.01.031","journal-title":"Cancer Lett"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djaa004","article-title":"Recent Trends in the Incidence and Survival of Stage 1A Pancreatic Cancer: A Surveillance, Epidemiology, and End Results Analysis","volume":"112","author":"Blackford AL","year":"2020","unstructured":"Blackford AL, Canto MI, Klein AP, Hruban RH, Goggins M. Recent Trends in the Incidence and Survival of Stage 1A Pancreatic Cancer: A Surveillance, Epidemiology, and End Results Analysis. J Natl Cancer Inst. 2020, 112:1162-9. 10.1093\/jnci\/djaa004","journal-title":"J Natl Cancer Inst"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v27.i17.1943","article-title":"BRCA mutated pancreatic cancer: A change is coming","volume":"27","author":"Rosen MN","year":"2021","unstructured":"Rosen MN, Goodwin RA, Vickers MM. BRCA mutated pancreatic cancer: A change is coming. World J Gastroenterol. 2021, 27:1943-58. 10.3748\/wjg.v27.i17.1943","journal-title":"World J Gastroenterol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15133423","article-title":"State-of-the-art and upcoming innovations in pancreatic cancer care: a step forward to precision medicine","volume":"15","author":"Schepis T","year":"2023","unstructured":"Schepis T, De Lucia SS, Pellegrino A, et al.. State-of-the-art and upcoming innovations in pancreatic cancer care: a step forward to precision medicine. Cancers (Basel). 2023, 15:10.3390\/cancers15133423","journal-title":"Cancers (Basel)"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.20524\/aog.2023.0827","article-title":"The impact of a multidisciplinary team approach on the management of focal pancreatic lesions: a single tertiary center experience","volume":"36","author":"Francisse S","year":"2023","unstructured":"Francisse S, Gkolfakis P, Viesca MF, et al.. The impact of a multidisciplinary team approach on the management of focal pancreatic lesions: a single tertiary center experience. Ann Gastroenterol. 2023, 36:580-7. 10.20524\/aog.2023.0827","journal-title":"Ann Gastroenterol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/307423-unraveling-pancreatic-cancer-epidemiology-risk-factors-and-global-trends","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T09:00:39Z","timestamp":1730451639000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/307423-unraveling-pancreatic-cancer-epidemiology-risk-factors-and-global-trends"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,1]]},"references-count":48,"URL":"https:\/\/doi.org\/10.7759\/cureus.72816","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,1]]}}}